1. |
|
|
2. |
- Ruilope, LM, et al.
(author)
-
Design and Baseline Characteristics of the Finerenone in Reducing Cardiovascular Mortality and Morbidity in Diabetic Kidney Disease Trial
- 2019
-
In: American journal of nephrology. - : S. Karger AG. - 1421-9670 .- 0250-8095. ; 50:5, s. 345-356
-
Journal article (peer-reviewed)abstract
- <b><i>Background:</i></b> Among people with diabetes, those with kidney disease have exceptionally high rates of cardiovascular (CV) morbidity and mortality and progression of their underlying kidney disease. Finerenone is a novel, nonsteroidal, selective mineralocorticoid receptor antagonist that has shown to reduce albuminuria in type 2 diabetes (T2D) patients with chronic kidney disease (CKD) while revealing only a low risk of hyperkalemia. However, the effect of finerenone on CV and renal outcomes has not yet been investigated in long-term trials. <b><i>Patients and</i></b> <b><i>Methods:</i></b> The Finerenone in Reducing CV Mortality and Morbidity in Diabetic Kidney Disease (FIGARO-DKD) trial aims to assess the efficacy and safety of finerenone compared to placebo at reducing clinically important CV and renal outcomes in T2D patients with CKD. FIGARO-DKD is a randomized, double-blind, placebo-controlled, parallel-group, event-driven trial running in 47 countries with an expected duration of approximately 6 years. FIGARO-DKD randomized 7,437 patients with an estimated glomerular filtration rate ≥25 mL/min/1.73 m<sup>2</sup> and albuminuria (urinary albumin-to-creatinine ratio ≥30 to ≤5,000 mg/g). The study has at least 90% power to detect a 20% reduction in the risk of the primary outcome (overall two-sided significance level α = 0.05), the composite of time to first occurrence of CV death, nonfatal myocardial infarction, nonfatal stroke, or hospitalization for heart failure. <b><i>Conclusions:</i></b> FIGARO-DKD will determine whether an optimally treated cohort of T2D patients with CKD at high risk of CV and renal events will experience cardiorenal benefits with the addition of finerenone to their treatment regimen. Trial Registration: EudraCT number: 2015-000950-39; ClinicalTrials.gov identifier: NCT02545049.
|
|
3. |
|
|
4. |
|
|
5. |
|
|
6. |
- Martel, I., et al.
(author)
-
An innovative Superconducting Recoil Separator for HIE-ISOLDE
- 2023
-
In: Nuclear Instruments and Methods in Physics Research, Section B: Beam Interactions with Materials and Atoms. - : ELSEVIER. - 0168-583X .- 1872-9584. ; 541, s. 176-179
-
Journal article (peer-reviewed)abstract
- The ISOLDE Scientific Infrastructure at CERN offers a unique range of post-accelerated radioactive beams. The scientific program can be improved with the “Isolde Superconducting Recoil Separator” (ISRS), an innovative spectrometer able to deliver unprecedented (A, Z) resolution. In this paper we present an overview of the physics and ongoing technical developments.
|
|
7. |
|
|
8. |
- Bonora, M, et al.
(author)
-
EPR of trans-stilbene radical cations formed in zeolite cavities : a new approach to study the zeolite void space
- 2000
-
In: Physical Chemistry, Chemical Physics - PCCP. - 1463-9076 .- 1463-9084. ; 2:20, s. 4823-4828
-
Journal article (peer-reviewed)abstract
- trans-Stilbene was adsorbed in the cavities of H-ZSM-5, H-MOR and H-BEA zeolites, originating monomeric and dimeric radical cations that were studied by EPR spectroscopy. The H-BEA samples were pretreated at three progressively higher temperatures. Simulation of the spectra allowed the evaluation of the relative amounts of monomers and dimers. The nature, quantity and relative amount of monomeric and dimeric radical species were correlated to chemical and dimensional modifications of zeolite channels caused by the dealumination of the zeolite structure and extra-framework aluminium species formation.
|
|
9. |
- Cretti, A., et al.
(author)
-
Assessment of beta-cell function during the oral glucose tolerance test by a minimal model of insulin secretion
- 2001
-
In: European Journal of Clinical Investigation. - : Wiley. - 0014-2972. ; 31:5, s. 405-416
-
Journal article (peer-reviewed)abstract
- Objective To characterise the performance of beta -cell during a standard oral glucose tolerance test (OGTT). Design Fifty-six subjects were studied. A minimal analogic model of beta -cell secretion during the OGTT was applied to all OGTTs (see below). The amount of insulin secreted over 120' in response to oral glucose (OGTT-ISR; Insulin Units 120'(-1) m(-2) BSA) and an index of beta -cell secretory 'force' (beta -lndex; pmol.min(-2).m(-2) BSA) were computed with the aid of the model. In protocol A, 10 healthy subjects underwent two repeat 75 g OGTT with frequent (every 10(/)-15(/)) blood sampling for glucose and C-peptide to test the reproducibility of OGTT-ISR and beta -Index with a complete or a reduced data set. In protocol B, 7 healthy subjects underwent three OGTTs (50, 100 or 150 g), to test the stability of the beta -Index under different glucose loads. In protocol C, 29 subjects (15 with normal glucose tolerance, 7 with impaired glucose tolerance and 7 with newly diagnosed type 2 diabetes) underwent two repeat 75 g OGTT with reduced (every 30' for 120') blood sampling to compare the reproducibility and the discriminant ratio (DR) of OGTT-ISR and beta -index with the insulinogenic index (IG-Index: Delta Insulin (30' - Basal)/Delta Glucose (30' - Basal)). In protocol D, 20 subjects (14 with normal glucose tolerance, 5 with impaired glucose tolerance and 1 with newly-diagnosed type 2 diabetes) underwent a 75 g OGTT and an intravenous glucose tolerance test (IVGTT) on separate days to explore the relationships between acute (0'-10') insulin response (ATR) during the IVGTT and beta -index and OGTT-ISR during the OGTT. Results In all protocols, the minimal analogic model of C-peptide secretion achieved a reasonable fit of the experimental data. In protocol A, a good reproducibility of both beta -index and OGTT-ISR was observed with both complete and reduced (every 30') data sets. In protocol B, increasing the oral glucose load caused progressive increases in OGTT-ISR (from 2.63 +/- 0.70 to 5.11 +/- 0.91 Units.120'(-1).m(-2) BSA; P < 0.01), but the -index stayed the same (4.14 +/- 0.35 vs. 4.29 +/- 0.30 vs. 4.30 +/- 0.33 pmol.min(-2).m(-2) BSA). In protocol C, both OGTT-ISR and beta -index had lower day-to-day CVs (17.6 +/- 2.2 and 12.4 +/- 2.4%, respectively) and higher DRs (2.57 and 1.74, respectively) than the IG-index (CV: 35.5 +/- 6.3%; DR: 0.934). OGTT-ISR was positively correlated to BMI (P < 0.03), whereas -index was inversely related to both fasting and 2 h plasma glucose (P < 0.01 for both). In protocol D, -index, but not OGTT-ISR was significantly correlated to ATR (r = 0.542, P < 0.02). Conclusions Analogically modelling -cell function during the OGTT provides a simple, useful tool for the physiological assessment of beta -cell function.
|
|
10. |
|
|
11. |
|
|
12. |
- Brustolon, M, et al.
(author)
-
Selective detection of EchoEPR signals due to naturally substituted C-13 radicals in a single crystal of ammonium tartrate
- 2001
-
In: Applied Magnetic Resonance. - 0937-9347 .- 1613-7507. ; 20:1-2, s. 171-188
-
Journal article (peer-reviewed)abstract
- Echo-detected electron paramagnetic resonance (echoEPR) profiles for irradiated deuterated ammonium tartrate single crystals depend strongly on the delays between pulses of the echo sequence. This is mainly due to instantaneous and spectral diffusion that plays a crucial role in determining the decay of the echo at every field position: the dephasing rate 1/T-M depends on the number of spins excited by the pulses and on the total number of interacting spins. A rigorous simulation of the echoEPR profiles at different delays requires the evaluation of the modulation pattern (ESEEM) and of the dephasing processes at every field position. From the simulations, information on the microscopic radical concentration, and on the electron-electron flip-flop rates of the single radical species can be obtained. Natural isotope C-13 substitution generates low-concentration radicals with relaxation properties different from the equivalent C-12-substitued radicals. The different behavior is discussed.
|
|
13. |
|
|
14. |
|
|
15. |
- Calcagno, A., et al.
(author)
-
Determinants of darunavir cerebrospinal fluid concentrations: impact of once-daily dosing and pharmacogenetics
- 2012
-
In: Aids. - 0269-9370. ; 26:12, s. 1529-1533
-
Journal article (peer-reviewed)abstract
- Objectives: To compare cerebrospinal fluid (CSF) darunavir and ritonavir concentrations in patients receiving darunavir/ritonavir 800/100 mg once daily or 600/100 mg twice daily. To determine the influence of single-nucleotide polymorphisms in the genes encoding for blood-brain barrier transporters (ABCB1 3435 C>T, ABCB1 1236 C>T, ABCB1 2677 G>T, SLCO1A2 38 A>G, SLCO1A2 516 A>C, ABCC2-24 G>A) on darunavir and ritonavir penetration into CSF. Design: Comparative pharmacokinetics study in patients. Methods: Plasma and CSF darunavir and ritonavir concentrations (2-26 h after drug intake) were determined by a validated HPLC coupled with mass spectrometry method in adults on darunavir-based combination antiretroviral therapy undergoing a lumbar puncture. Results: HIV-infected patients on once-daily darunavir/ritonavir had significantly lower CSF darunavir trough concentrations and CSF-to-plasma ratios than patients on darunavir/ritonavir twice-daily (10.7 versus 38.2 ng/ml and 0.32 versus 0.90%; P < 0.05). No significant effect of single-nucleotide polymorphisms in the genes encoding for blood-brain barrier transporters was noted apart from slightly higher CSF darunavir penetration in patients carrying OATP1A2 uncommon variants. Conclusions: This is the first study to compare darunavir CSF concentrations in patients taking the once-daily or the twice-daily dosage: our data show that darunavir and ritonavir dosing significantly affects not only CSF concentrations but also the extent of drug penetration into the CSF. Furthermore a minority of patients in the once-daily arm presented very low CSF concentration of potential concern for HIV control in the central nervous system. The relative importance of pharmacogenetics in influencing CSF darunavir pharmacokinetics deserves further clinical investigation. (C) 2012 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins
|
|
16. |
- Liu, W, et al.
(author)
-
Structure and dynamics of radicals in zeolite matrices : ESR and theoretical studies
- 2003
-
In: Applied Magnetic Resonance. - 0937-9347 .- 1613-7507. ; 24:3-4, s. 285-302
-
Journal article (peer-reviewed)abstract
- Amine radical cations of the type R3N.+ and [R3NCH2](.+), R = CH3, C2H5, C3H7, and nitric oxide, NO, have been used to probe the bonding to the surface and the dynamics of the radicals trapped in the confined space of cages or channels in the zeolite. Regular continuous-wave electron spin resonance (ESR) was employed to study the internal motion of the cation radicals formed by gamma-irradiation of amines and related ammonium ions, introduced during the synthesis of the zeolites Al-offretite, SAPO-37, SAPO-42 and AlPO4-5. The ESR spectra of [(CH3)(3)NCH2](.+) radical cation in several studied systems changed reversibly with temperature, indicating dynamical effects. Free rotation about the >N-CH2 bond of the [(CH3)(3)NCH2](.+) species was found to occur in the temperature range of 110 to 300 K, while the rotation about the >N-CH3 bonds was hindered. The observations confirm the theoretical prediction on the basis of density functional theory calculations, which indicate that the corresponding barriers are of the order of 0.3 and 7 kJ/mol, respectively. The radical cations of the type R3N.+ with R = C2H5, C3H7 were found to undergo a different type of dynamics, involving a two-jump process of the methylene hydrogens next to the nitrogen. A cage or channel size effect on the stability and molecular dynamics was inferred in some cases. Pulsed ESR was employed to study the (NO)(2) triplet-state dimers in Na-A type zeolite, with the purpose to resolve the interaction with surface groups, and to elucidate the role of the zeolite on stabilizing the triplet rather than the usual singlet state. Measurements performed at 5 K gave rise to Fourier transform spectra that were assigned to the dimer species interacting with one or more Na-23 nuclei, with approximative parameters A(Na-23) = (4.6, 4.6, 8.2) MHz and Q(Na-23) = (-0.3, -0.3, 0.6) MHz for the hyperfine and nuclear quadrupole coupling tensors, respectively. The values are of similar magnitude as those determined for the NO---Na+ complex. The stability of the triplet-state structure was attributed to an unusual geometric structure imposed by the zeolite matrix, with the N-O bonds along a line as in [O-N---Na+---N-O], which according to UHF ab initio calculations has a triplet ground state.
|
|
17. |
|
|
18. |
- Biglino, D., et al.
(author)
-
Pulsed EPR study of the (NO)2-Na+ triplet state adsorption complex
- 2001
-
In: Chemical Physics Letters. - 0009-2614 .- 1873-4448. ; 349:5-6, s. 511-516
-
Journal article (peer-reviewed)abstract
- The (NO)2-Na+ triplet state complex stabilised in Na-A zeolites at low temperature was studied by pulsed EPR. The 3-pulse ESEEM spectra at 5 K were analysed by simulations in the time-domain, followed by Fourier transformation. The ESEEM was attributed to the interaction with Na+. The hyperfine coupling A(23Na)=(4.6, 4.6, 8.2) MHz and nuclear quadrupole Q(23Na)=(0.3, 0,3, -0.6) MHz tensors are of comparable magnitude as in the NO-Na+ complex determined earlier. The complexes are proposed to be either pairs of NO-Na+ or ON-Na+-NO.
|
|
19. |
|
|
20. |
- Calcagno, A., et al.
(author)
-
Cerebrospinal fluid abacavir concentrations in HIV-positive patients following once-daily administration
- 2018
-
In: British Journal of Clinical Pharmacology. - : Wiley. - 0306-5251. ; 84:6, s. 1380-1383
-
Journal article (peer-reviewed)abstract
- Abacavir is a widely used nucleotide reverse transcriptase inhibitor, for which cerebrospinal fluid (CSF) exposure has been previously assessed in twice-daily recipients. We studied abacavir CSF concentrations in 61 and nine HIV-positive patients taking abacavir once daily and twice daily, respectively. Patients on once-daily abacavir had higher plasma and CSF concentrations (96 vs. 22ngml(-1), P = 0.038 and 123 vs. 49ngml(-1), P=0.038) but similar CSF-to-plasma ratios (0.8 vs. 0.5, P=0.500). CSF abacavir concentrations were adequate in patients receiving once-daily treatment.
|
|
21. |
- Hennig, Stefanie, et al.
(author)
-
Population pharmacokinetic drug-drug interaction pooled analysis of existing data for rifabutin and HIV PIs
- 2016
-
In: Journal of Antimicrobial Chemotherapy. - : Oxford University Press (OUP). - 0305-7453 .- 1460-2091. ; 71:5, s. 1330-1340
-
Journal article (peer-reviewed)abstract
- OBJECTIVES: Extensive but fragmented data from existing studies were used to describe the drug-drug interaction between rifabutin and HIV PIs and predict doses achieving recommended therapeutic exposure for rifabutin in patients with HIV-associated TB, with concurrently administered PIs.METHODS: Individual-level data from 13 published studies were pooled and a population analysis approach was used to develop a pharmacokinetic model for rifabutin, its main active metabolite 25-O-desacetyl rifabutin (des-rifabutin) and drug-drug interaction with PIs in healthy volunteers and patients who had HIV and TB (TB/HIV).RESULTS: Key parameters of rifabutin affected by drug-drug interaction in TB/HIV were clearance to routes other than des-rifabutin (reduced by 76%-100%), formation of the metabolite (increased by 224% in patients), volume of distribution (increased by 606%) and distribution to the peripheral compartment (reduced by 47%). For des-rifabutin, clearance was reduced by 35%-76% and volume of distribution increased by 67%-240% in TB/HIV. These changes resulted in overall increased exposure to rifabutin in TB/HIV patients by 210% because of the effects of PIs and 280% with ritonavir-boosted PIs.CONCLUSIONS: Given together with non-boosted or ritonavir-boosted PIs, rifabutin at 150 mg once daily results in similar or higher exposure compared with rifabutin at 300 mg once daily without concomitant PIs and may achieve peak concentrations within an acceptable therapeutic range. Although 300 mg of rifabutin every 3 days with boosted PI achieves an average equivalent exposure, intermittent doses of rifamycins are not supported by current guidelines.
|
|
22. |
- Lund, Anders, et al.
(author)
-
New materials for ESR dosimetry
- 2002
-
In: Spectrochimica Acta Part A - Molecular and Biomolecular Spectroscopy. - 1386-1425 .- 1873-3557. ; 58:6, s. 1301-1311
-
Journal article (peer-reviewed)abstract
- New materials for electron spin resonance (ESR) dosimetry have been investigated with the aim to find systems more sensitive than L-alanine accepted as a standard for high dose determinations. Among the investigated systems ammonium tartrate, 2-methylalanine, salts of formic acids and dithionates have been found to be more sensitive than alanine by a factor 2-10. The lower limit applies to tissue equivalent materials, while much higher sensitivities were obtained with formates and dithionates containing heavier atoms. The increased sensitivity was mainly attributed to suitable ESR properties of the room temperature stable radicals as regards spectral shape (narrow lines, little or no hyperfine structure) and microwave saturation properties (short relaxation times). The radical structures have when necessary been clarified by ENDOR spectroscopy, while the saturation properties have been screened by pulsed ESR measurements.
|
|
23. |
|
|